AJP - Lung Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 286: L514-L520, 2004. First published October 31, 2003; doi:10.1152/ajplung.00099.2003
1040-0605/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/3/L514    most recent
00099.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spencer, L. T.
Right arrow Articles by Brantly, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spencer, L. T.
Right arrow Articles by Brantly, M. L.

TRANSLATIONAL PHYSIOLOGY

Role of human neutrophil peptides in lung inflammation associated with {alpha}1-antitrypsin deficiency

L. Terry Spencer,1 Gregorino Paone,2 Peter M. Krein,2 Farshid N. Rouhani,2 Jesus Rivera-Nieves,2 and Mark L. Brantly3

1Division of Pulmonary Diseases, Department of Pediatrics, and 3Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Florida College of Medicine, Gainesville, Florida 32610; and 2Clinical Studies Section, Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892

Submitted 3 April 2003 ; accepted in final form 28 October 2003

Individuals with {alpha}1-antitrypsin ({alpha}1-AT) deficiency are at risk for early-onset destructive lung disease as a result of insufficient lower respiratory tract {alpha}1-AT and an increased burden of neutrophil products such as elastase. Human neutrophil peptides (HNP), the most abundant protein component of neutrophil azurophilic granules, represent another potential inflammatory component in lung disease characterized by increased numbers of activated or deteriorating neutrophils. The purpose of this study was to determine the role of HNP in lower respiratory tract inflammation and destruction occuring in {alpha}1-AT deficiency. {alpha}1-AT-deficient individuals (n = 33) and healthy control subjects (n = 21) were evaluated by bronchoalveolar lavage. HNP concentrations were significantly higher in {alpha}1-AT-deficient individuals (1,976 ± 692 vs. 29 ± 12 nM, P < 0.0001), and levels correlated with markers of neutrophil-mediated lung inflammation. In vitro, HNP produced a dose-dependent cytotoxic effect on alveolar macrophages and stimulated production of the potent neutrophil chemoattractants leukotriene B4 and interleukin-8 by alveolar macrophages, with a 6- to 10-fold increase in chemoattractant production over negative control cultures (P < 0.05). A synergistic effect was noted between HNP and neutrophil elastase with regard to leukotriene B4 production. Importantly, the proinflammatory effects of HNP were blocked by {alpha}1-AT. HNP likely play an important role in amplifying and maintaining neutrophil-mediated inflammation in the lungs.

pulmonary emphysema; granulocytes; alveolar macrophages; serpins


Address for reprint requests and other correspondence: L. T. Spencer, Div. of Pulmonary Diseases, Dept. of Pediatrics, Univ. of Florida College of Medicine, PO Box 100296, Gainesville, FL 32610-0296 (E-mail: spenclt{at}peds.ufl.edu).




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Voglis, K. Quinn, E. Tullis, M. Liu, M. Henriques, C. Zubrinich, O. Penuelas, H. Chan, F. Silverman, V. Cherepanov, et al.
Human Neutrophil Peptides and Phagocytic Deficiency in Bronchiectatic Lungs
Am. J. Respir. Crit. Care Med., July 15, 2009; 180(2): 159 - 166.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
J. Chang and Z. Mosenifar
Differentiating COPD From Asthma in Clinical Practice
J Intensive Care Med, September 1, 2007; 22(5): 300 - 309.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
Y. Yamaguchi, T. Nagase, T. Tomita, K. Nakamura, S. Fukuhara, T. Amano, H. Yamamoto, Y. Ide, M. Suzuki, S. Teramoto, et al.
beta-Defensin overexpression induces progressive muscle degeneration in mice
Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2141 - C2149.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Paone, L. A. Stevens, R. L. Levine, C. Bourgeois, W. K. Steagall, B. R. Gochuico, and J. Moss
ADP-ribosyltransferase-specific Modification of Human Neutrophil Peptide-1
J. Biol. Chem., June 23, 2006; 281(25): 17054 - 17060.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
O. Senn, E. W. Russi, M. Imboden, and N. M. Probst-Hensch
{alpha}1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants
Eur. Respir. J., November 1, 2005; 26(5): 909 - 917.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. R. Pons, J. Sauleda, A. Noguera, J. Pons, B. Barcelo, A. Fuster, and A. G. N. Agusti
Decreased macrophage release of TGF-{beta} and TIMP-1 in chronic obstructive pulmonary disease
Eur. Respir. J., July 1, 2005; 26(1): 60 - 66.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. van Wetering, G. S. Tjabringa, and P. S. Hiemstra
Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells
J. Leukoc. Biol., April 1, 2005; 77(4): 444 - 450.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.